Chronic kidney disease and hypertension

A man wearing a blood pressure armband.

Project: Chronic kidney disease (CKD) and hypertension in NHS Central Manchester and Bury Clinical Commissioning Groups

What did we do?

NHS Central Manchester Clinical Commissioning Group

This was a three year project to spread the CKD IMPAKT™ work across three localities in NHS Central Manchester CCG. The aim of this work was to increase the knowledge of healthcare professionals and improve the quality of services and care provided to CKD patients.

NHS Bury CCG

This was a two year project to spread the CKD IMPAKT™ work across two sectors in NHS Bury CCG.

Why was it important?

Excess cardiovascular disease related to CKD is thought to cost the NHS in England £175 million each year. With end stage CKD growing at an estimated 6% per annum, diagnosing and treating CKD effectively as early as possible is hugely important.

The project aimed to result in:

  • Primary care clinicians being more confident in the coding and management of CKD.
  • An increase in CKD diagnoses (finding patients with CKD who do not currently have a diagnosis).
  • Improvements in the management of CKD patients.
  • Primary care staff being more confident in the use of quality improvement methods which can be transferred to other projects/activity.
  • An increased spread and sustainability of the project across a whole CCG.

How did we do it?

We focussed on halving the gap between the recorded and estimated prevalence of CKD on practice registers. We also worked towards 75% of CKD patients being tested for proteinuria and managed to National Institute for Health and Care Excellence (NICE) recommended blood pressure targets.

Who did we work with?

NHS Central Manchester CCG and NHS Bury CCG.

Results

NHS Central Manchester CCG

View the report for Central Manchester CCG: Hulme, Moss Side and Rusholme locality for April 2013 – March 2014 (PDF).

View the report for May 2014 – April 2015 (PDF).

View the report for August 2016 (PDF).

NHS Bury CCG

View the report for August 2016 (PDF).

More information

For further information, please contact Dr Susan Howard, Programme Manager, or Dr Tom Blakeman, academic/clinical lead.